BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

PolyPid Announces Revolutionary Drug Delivery System and an Innovative Biodegradable Bone Void Filler


5/6/2011 10:14:28 AM

Ness Ziona, Israel, May 6, 2011. PolyPid, a developer of innovative drug carriers, announced today the company’s flagship platform – PolyPid. PolyPid is a new, innovative family of drug carriers, based on a fusion between two known drug delivery systems: polymers and lipid-based systems.

The new drug carriers enable long-lasting and controlled release of therapeutic drugs. The revolutionary, patented carrier can be tailored to almost any drug – small molecules, peptides, protein and nucleic acids-based drugs. The formulations can be pre-planned in order to achieve the desired release rate of the drug/s and the optimal duration, which can last up to several months.

“PolyPid is a groundbreaking drug carrier that will help pharmaceutical and biotech companies enhance their drugs and meet their challenges,” said Dr. Noam Emanuel, PolyPid’s Chief Technology Officer. “Due to its flexibility, the PolyPid platform can be utilized to address numerous medical indications in various fields, such as orthopedics, urology, periodontal, anti-cancer/anti-fungal treatments and surgical accessories.”

PolyPid technology makes it possible to entrap a large variety of one or more biologically active molecules, and to release them at a pre-programmed rate for up to several months, all according to the desired clinical rate. During its long-lasting effect the drug reservoir is fully protected from both bio-degradation and hydration.

The first PolyPid-based solution is BonyPidTM, biodegradable bone void filler that is micro-coated with a PolyPid biodegradable formulation. The coating gradually releases one or more selected antibiotics into its surroundings. Subsequently, the bone void filler scaffold remains and supports bone recovery. Thus, using BonyPidTM will not change the current method of treatment that used bone grafting. The physician will simply replace the conventional bone void filler with BonyPidTM to obtain the benefits of conventional bone void filler combined with an effective local drug delivery system.

About PolyPid

Founded in 2008 and located in Israel, PolyPid has developed a new, innovative family of drug carriers, based on a fusion between polymers and lipid-based systems. The new drug carriers enable long-lasting and controlled release of therapeutic drugs. The revolutionary, patented carrier can be tailored to almost any drug – small molecules, peptides, protein and nucleic acids-based drugs. Due to its flexibility, the PolyPid platform can be utilized to address numerous medical indications in various fields, such as orthopedics, urology, periodontal, anti-cancer/anti-fungal treatments and surgical accessories. PolyPid Ltd. is owned by Xenia Venture Capital, private investors and the founders. For more information about PolyPid, visit www.polypid.com

Contact:

David Kanaan

Kanaan Public Relations

Tel.: +972-54-4255307

e-mail: David@KanaanPR.com

www.kanaanpr.com



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES